{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T05:01:37Z","timestamp":1794114097025,"version":"4.8.0"},"reference-count":136,"publisher":"Oxford University Press (OUP)","issue":"Supplement_4","license":[{"start":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T00:00:00Z","timestamp":1620345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Janssen Pharmaceutical Companies of Johnson & Johnson"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Several lines of evidence point towards the central role of IL-23 as a crucial inflammatory mediator in the pathogenesis of SpA\u2014a group of inflammatory arthritic diseases whose symptoms span the skin, gastrointestinal tract and joints. While therapeutic blockade of IL-23 proved successful in the treatment of IBD, psoriatic skin disease and peripheral SpA, it failed in patients suffering from SpA with predominantly axial involvement. Here we review state-of-the-art discoveries on IL-23 signalling pathways across target tissues involved in SpA. We discuss the discrepancies in resident IL-23\u2013responding cells and their downstream activities across skin, gut and joint that shape the unique immunological landscape of SpA.<\/jats:p>","DOI":"10.1093\/rheumatology\/keab385","type":"journal-article","created":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T13:12:28Z","timestamp":1620306748000},"page":"iv16-iv27","source":"Crossref","is-referenced-by-count":36,"title":["Crossing the boundaries: IL-23 and its role in linking inflammation of the skin, gut and joints"],"prefix":"10.1093","volume":"60","author":[{"given":"Zuzanna","family":"\u0141ukasik","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Pediatrics, UZ Ghent"},{"name":"VIB Center for Inflammation Research, Ghent University, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Gracey","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Pediatrics, UZ Ghent"},{"name":"VIB Center for Inflammation Research, Ghent University, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Venken","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Pediatrics, UZ Ghent"},{"name":"VIB Center for Inflammation Research, Ghent University, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Ritchlin","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Elewaut","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Pediatrics, UZ Ghent"},{"name":"VIB Center for Inflammation Research, Ghent University, Ghent, Belgium"},{"name":"Ghent Gut Inflammation Group, Ghent University, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,5,7]]},"reference":[{"key":"2021102006535429100_keab385-B1","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(11)60071-8","article-title":"Spondyloarthritis","volume":"377","author":"Dougados","year":"2011","journal-title":"Lancet"},{"key":"2021102006535429100_keab385-B2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nri3707","article-title":"The IL-23\u2013IL-17 immune axis: from mechanisms to therapeutic testing","volume":"14","author":"Gaffen","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"2021102006535429100_keab385-B3","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jaci.2014.11.001","article-title":"The 3 major types of innate and adaptive cell-mediated effector immunity","volume":"135","author":"Annunziato","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"2021102006535429100_keab385-B4","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/annrheumdis-2012-202135","article-title":"Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model","volume":"72","author":"Van Praet","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2021102006535429100_keab385-B5","first-page":"2279","article-title":"The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint","volume":"22","author":"Mielants","year":"1995","journal-title":"J Rheumatol"},{"key":"2021102006535429100_keab385-B6","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/annrheumdis-2013-203854","article-title":"Degree of bone marrow oedema in sacroiliac joints of patients with axial spondyloarthritis is linked to gut inflammation and male sex: results from the GIANT cohort","volume":"73","author":"Van Praet","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2021102006535429100_keab385-B7","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMra1505557","article-title":"Psoriatic arthritis","volume":"376","author":"Ritchlin","year":"2017","journal-title":"N Engl J Med"},{"key":"2021102006535429100_keab385-B8","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","article-title":"Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12","volume":"13","author":"Oppmann","year":"2000","journal-title":"Immunity"},{"key":"2021102006535429100_keab385-B9","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ni.2366","article-title":"IL-12 family cytokines: immunological playmakers","volume":"13","author":"Vignali","year":"2012","journal-title":"Nat Immunol"},{"key":"2021102006535429100_keab385-B10","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00011-019-01235-x","article-title":"The IL-23p19\/EBI3 heterodimeric cytokine termed IL-39 remains a theoretical cytokine in man","volume":"68","author":"Bridgewood","year":"2019","journal-title":"Inflamm Res"},{"key":"2021102006535429100_keab385-B11","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s41584-019-0294-7","article-title":"The IL-23\u2013IL-17 pathway as a therapeutic target in axial spondyloarthritis","volume":"15","author":"Sieper","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"2021102006535429100_keab385-B12","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1074\/jbc.RA120.012943","article-title":"Inflammatory and mitogenic signals drive interleukin 23 subunit alpha (IL23A) secretion independent of IL12B in intestinal epithelial cells","volume":"295","author":"Lim","year":"2020","journal-title":"J Biol Chem"},{"key":"2021102006535429100_keab385-B13","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/SHK.0b013e31828f9c92","article-title":"CD11c+ alveolar macrophages are a source of IL-23 during lipopolysaccharide-induced acute lung injury","volume":"39","author":"Bosmann","year":"2013","journal-title":"Shock"},{"key":"2021102006535429100_keab385-B14","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/art.24389","article-title":"Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis","volume":"60","author":"Ciccia","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2021102006535429100_keab385-B15","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1074\/jbc.M207577200","article-title":"Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17","volume":"278","author":"Aggarwal","year":"2003","journal-title":"J Biol Chem"},{"key":"2021102006535429100_keab385-B16","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"key":"2021102006535429100_keab385-B17","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"2021102006535429100_keab385-B18","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.4049\/jimmunol.0900732","article-title":"Cutting edge: IL-23 receptor GFP reporter mice reveal distinct populations of IL-17\u2013producing cells","volume":"182","author":"Awasthi","year":"2009","journal-title":"J Immunol"},{"key":"2021102006535429100_keab385-B19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.chom.2009.02.006","article-title":"The macrophage mannose receptor induces IL-17 in response to Candida albicans","volume":"5","author":"van de Veerdonk","year":"2009","journal-title":"Cell Host Microbe"},{"key":"2021102006535429100_keab385-B20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J Exp Med"},{"key":"2021102006535429100_keab385-B21","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature09447","article-title":"Generation of pathogenic Th17 cells in the absence of TGF-\u03b2 signalling","volume":"467","author":"Ghoreschi","year":"2010","journal-title":"Nature"},{"key":"2021102006535429100_keab385-B22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","article-title":"TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17\u2013producing T cells","volume":"24","author":"Veldhoen","year":"2006","journal-title":"Immunity"},{"key":"2021102006535429100_keab385-B23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature04754","article-title":"Transforming growth factor-beta induces development of the TH17 lineage","volume":"441","author":"Mangan","year":"2006","journal-title":"Nature"},{"key":"2021102006535429100_keab385-B24","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.4049\/jimmunol.170.9.4432","article-title":"Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection","volume":"170","author":"Happel","year":"2003","journal-title":"J Immunol"},{"key":"2021102006535429100_keab385-B25","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.1128\/IAI.00621-06","article-title":"Neutralization or absence of the interleukin-23 pathway does not compromise immunity to mycobacterial infection","volume":"74","author":"Chackerian","year":"2006","journal-title":"Infect Immun"},{"key":"2021102006535429100_keab385-B26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2017.12.007","article-title":"A cellular and molecular view of T helper 17 cell plasticity in autoimmunity","volume":"87","author":"Stadhouders","year":"2018","journal-title":"J Autoimmun"},{"key":"2021102006535429100_keab385-B27","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","article-title":"IL-23 induces spondyloarthropathy by acting on ROR-\u03b3t+ CD3+CD4\u2013CD8\u2013 entheseal resident T cells","volume":"18","author":"Sherlock","year":"2012","journal-title":"Nat Med"},{"key":"2021102006535429100_keab385-B28","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1136\/annrheumdis-2015-208902","article-title":"IL-7 primes IL-17 in mucosal-associated invariant T (MAIT) cells, which contribute to the Th17-axis in ankylosing spondylitis","volume":"75","author":"Gracey","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2021102006535429100_keab385-B29","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/mi.2009.99","article-title":"NKT cells in mucosal immunity","volume":"2","author":"Middendorp","year":"2009","journal-title":"Mucosal Immunol"},{"key":"2021102006535429100_keab385-B30","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.3389\/fimmu.2018.01489","article-title":"It takes \u201cguts\u201d to cause joint inflammation: role of innate-like T cells","volume":"9","author":"Mortier","year":"2018","journal-title":"Front Immunol"},{"key":"2021102006535429100_keab385-B31","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.immuni.2009.08.001","article-title":"Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity","volume":"31","author":"Sutton","year":"2009","journal-title":"Immunity"},{"key":"2021102006535429100_keab385-B32","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/art.33321","article-title":"Proinflammatory Th17 cells are expanded and induced by dendritic cells in spondylarthritis-prone HLA-B27-transgenic rats","volume":"64","author":"Glatigny","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2021102006535429100_keab385-B33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.immuni.2009.06.020","article-title":"Interleukin-17\u2013producing gammadelta T cells selectively expand in response to pathogen products and environmental signals","volume":"31","author":"Martin","year":"2009","journal-title":"Immunity"},{"key":"2021102006535429100_keab385-B34","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.4049\/jimmunol.180.8.5167","article-title":"Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion","volume":"180","author":"Rachitskaya","year":"2008","journal-title":"J Immunol"},{"key":"2021102006535429100_keab385-B35","doi-asserted-by":"crossref","first-page":"585134","DOI":"10.3389\/fimmu.2020.585134","article-title":"Interleukin (IL)-12 and IL-18 synergize to promote MAIT Cell IL-17A and IL-17F production independently of IL-23 signaling","volume":"11","author":"Cole","year":"2020","journal-title":"Front Immunol"},{"key":"2021102006535429100_keab385-B36","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.15252\/embr.201744200","article-title":"IL-23 drives differentiation of peripheral \u03b3\u03b417 T cells from adult bone marrow\u2013derived precursors","volume":"18","author":"Papotto","year":"2017","journal-title":"EMBO Rep"},{"key":"2021102006535429100_keab385-B37","doi-asserted-by":"crossref","first-page":"eaaw0402","DOI":"10.1126\/sciimmunol.aaw0402","article-title":"IL-23 costimulates antigen-specific MAIT cell activation and enables vaccination against bacterial infection","volume":"4","author":"Wang","year":"2019","journal-title":"Sci Immunol"},{"key":"2021102006535429100_keab385-B38","doi-asserted-by":"crossref","first-page":"e3000646","DOI":"10.1371\/journal.pbio.3000646","article-title":"IL-23 signaling regulation of pro-inflammatory T-cell migration uncovered by phosphoproteomics","volume":"18","author":"\u00c1lvarez-Salamero","year":"2020","journal-title":"PLoS Biol"},{"key":"2021102006535429100_keab385-B39","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.4049\/jimmunol.1501921","article-title":"Effector \u03b3\u03b4 T cell differentiation relies on master but not auxiliary Th cell transcription factors","volume":"196","author":"Barros-Martins","year":"2016","journal-title":"J Immunol"},{"key":"2021102006535429100_keab385-B40","doi-asserted-by":"crossref","first-page":"5758","DOI":"10.4049\/jimmunol.1003043","article-title":"Proinflammatory environment dictates the IL-17\u2013producing capacity of human invariant NKT cells","volume":"186","author":"Moreira-Teixeira","year":"2011","journal-title":"J Immunol"},{"key":"2021102006535429100_keab385-B41","doi-asserted-by":"crossref","first-page":"19845","DOI":"10.1073\/pnas.0806472105","article-title":"Critical role of ROR-\u03b3t in a new thymic pathway leading to IL-17\u2013producing invariant NKT cell differentiation","volume":"105","author":"Michel","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021102006535429100_keab385-B42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.smim.2015.01.001","article-title":"Epigenetic and transcriptional regulation of \u03b3\u03b4 T cell differentiation: programming cells for responses in time and space","volume":"27","author":"Schmolka","year":"2015","journal-title":"Semin Immunol"},{"key":"2021102006535429100_keab385-B43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.20072713","article-title":"Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22","volume":"206","author":"Takatori","year":"2009","journal-title":"J Exp Med"},{"key":"2021102006535429100_keab385-B44","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.immuni.2015.11.009","article-title":"Interleukin-23\u2013induced transcription factor blimp-1 promotes pathogenicity of T helper 17 cells","volume":"44","author":"Jain","year":"2016","journal-title":"Immunity"},{"key":"2021102006535429100_keab385-B45","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/ni.1993","article-title":"Fate mapping of IL-17\u2013producing T cells in inflammatory responses","volume":"12","author":"Hirota","year":"2011","journal-title":"Nat Immunol"},{"key":"2021102006535429100_keab385-B46","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1136\/gutjnl-2018-316830","article-title":"IL23 induces IL23R recycling and amplifies innate receptor-induced signalling and cytokines in human macrophages, and the IBD-protective IL23R R381Q variant modulates these outcomes","volume":"69","author":"Sun","year":"2020","journal-title":"Gut"},{"key":"2021102006535429100_keab385-B47","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1038\/s41598-019-41655-7","article-title":"Monocytes\/macrophages play a pathogenic role in IL-23 mediated psoriasis-like skin inflammation","volume":"9","author":"Wang","year":"2019","journal-title":"Sci Rep"},{"key":"2021102006535429100_keab385-B48","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s13238-018-0505-z","article-title":"IL-23\u2013induced macrophage polarization and its pathological roles in mice with imiquimod-induced psoriasis","volume":"9","author":"Hou","year":"2018","journal-title":"Protein Cell"},{"key":"2021102006535429100_keab385-B49","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41435-019-0067-y","article-title":"The IL-23\/IL-17 pathway in human chronic inflammatory diseases\u2014new insight from genetics and targeted therapies","volume":"20","author":"Bianchi","year":"2019","journal-title":"Genes Immun"},{"key":"2021102006535429100_keab385-B50","doi-asserted-by":"crossref","first-page":"9560","DOI":"10.1073\/pnas.1017854108","article-title":"Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses","volume":"108","author":"Sarin","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021102006535429100_keab385-B51","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.rdc.2020.01.007","article-title":"Intestinal microbiota, HLA-B27, and spondyloarthritis: dangerous liaisons","volume":"46","author":"Dumas","year":"2020","journal-title":"Rheum Dis Clin North Am"},{"key":"2021102006535429100_keab385-B52","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1136\/annrheumdis-2016-211064","article-title":"Faecal microbiota study reveals specific dysbiosis in spondyloarthritis","volume":"76","author":"Breban","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2021102006535429100_keab385-B53","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/art.39802","article-title":"Brief report: dialister as a microbial marker of disease activity in spondyloarthritis","volume":"69","author":"Tito","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2021102006535429100_keab385-B54","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1136\/annrheumdis-2016-210000","article-title":"Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis","volume":"76","author":"Ciccia","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2021102006535429100_keab385-B55","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s40168-018-0533-1","article-title":"Alteration of the cutaneous microbiome in psoriasis and potential role in Th17 polarization","volume":"6","author":"Chang","year":"2018","journal-title":"Microbiome"},{"key":"2021102006535429100_keab385-B56","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/ard.60.4.337","article-title":"Frequency of triggering bacteria in patients with reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used for diagnosis","volume":"60","author":"Fendler","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"2021102006535429100_keab385-B57","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1084\/jem.180.6.2359","article-title":"The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats","volume":"180","author":"Taurog","year":"1994","journal-title":"J Exp Med"},{"key":"2021102006535429100_keab385-B58","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2020.11.032","article-title":"Short-term Western diet intake promotes IL-23\u2012mediated skin and joint inflammation accompanied by changes to the gut microbiota in mice","author":"Shi","year":"2021","journal-title":"J Invest Dermatol"},{"key":"2021102006535429100_keab385-B59","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","article-title":"Induction of intestinal Th17 cells by segmented filamentous bacteria","volume":"139","author":"Ivanov","year":"2009","journal-title":"Cell"},{"key":"2021102006535429100_keab385-B60","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0140-6736(92)90399-N","article-title":"Detection of Chlamydia trachomatis DNA in joints of reactive arthritis patients by polymerase chain reaction","volume":"340","author":"Taylor-Robinson","year":"1992","journal-title":"Lancet"},{"key":"2021102006535429100_keab385-B61","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0140-6736(90)90804-E","article-title":"Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis","volume":"335","author":"Granfors","year":"1990","journal-title":"Lancet"},{"key":"2021102006535429100_keab385-B62","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/1529-0131(200003)43:3<593::AID-ANR16>3.0.CO;2-1","article-title":"Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides","volume":"43","author":"van der Heijden","year":"2000","journal-title":"Arthritis Rheum"},{"key":"2021102006535429100_keab385-B63","doi-asserted-by":"crossref","first-page":"14305","DOI":"10.1038\/s41598-018-32675-w","article-title":"Detection and characterization of bacterial nucleic acids in culture-negative synovial tissue and fluid samples from rheumatoid arthritis or osteoarthritis patients","volume":"8","author":"Zhao","year":"2018","journal-title":"Sci Rep"},{"key":"2021102006535429100_keab385-B64","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/BOR.0000000000000296","article-title":"Intestinal dysbiosis and innate immune responses in axial spondyloarthritis","volume":"28","author":"Ciccia","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"2021102006535429100_keab385-B65","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/annrheumdis-2018-214381","article-title":"IL-23 favours outgrowth of spondyloarthritis-associated pathobionts and suppresses host support for homeostatic microbiota","volume":"78","author":"Rehaume","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2021102006535429100_keab385-B66","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1016\/j.celrep.2016.07.054","article-title":"Epithelial IL-23R signaling licenses protective IL-22 responses in intestinal inflammation","volume":"16","author":"Aden","year":"2016","journal-title":"Cell Rep"},{"key":"2021102006535429100_keab385-B67","doi-asserted-by":"crossref","first-page":"13942","DOI":"10.1073\/pnas.1323852111","article-title":"Homeostatic IL-23 receptor signaling limits Th17 response through IL-22\u2013mediated containment of commensal microbiota","volume":"111","author":"Shih","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021102006535429100_keab385-B68","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1038\/s41467-019-13538-y","article-title":"Flagellin-elicited adaptive immunity suppresses flagellated microbiota and vaccinates against chronic inflammatory diseases","volume":"10","author":"Tran","year":"2019","journal-title":"Nat Commun"},{"key":"2021102006535429100_keab385-B69","doi-asserted-by":"crossref","first-page":"e5076","DOI":"10.1073\/pnas.1718902115","article-title":"A cytokine network involving IL-36\u03b3, IL-23, and IL-22 promotes antimicrobial defense and recovery from intestinal barrier damage","volume":"115","author":"Ngo","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021102006535429100_keab385-B70","doi-asserted-by":"crossref","first-page":"e20192195","DOI":"10.1084\/jem.20192195","article-title":"The role of IL-22 in intestinal health and disease","volume":"217","author":"Keir","year":"2020","journal-title":"J Exp Med"},{"key":"2021102006535429100_keab385-B71","doi-asserted-by":"crossref","first-page":"eaau6571","DOI":"10.1126\/sciimmunol.aau6571","article-title":"IL-23 producing IL-10R\u03b1\u2013deficient gut macrophages elicit an IL-22\u2013driven proinflammatory epithelial cell response","volume":"4","author":"Bernshtein","year":"2019","journal-title":"Sci Immunol"},{"key":"2021102006535429100_keab385-B72","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1126\/science.aah5903","article-title":"A pathogenic role for T cell\u2013derived IL-22BP in inflammatory bowel disease","volume":"354","author":"Pelczar","year":"2016","journal-title":"Science"},{"key":"2021102006535429100_keab385-B73","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.immuni.2009.06.008","article-title":"Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity","volume":"31","author":"Colonna","year":"2009","journal-title":"Immunity"},{"key":"2021102006535429100_keab385-B74","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1084\/jem.20101712","article-title":"IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease","volume":"208","author":"Geremia","year":"2011","journal-title":"J Exp Med"},{"key":"2021102006535429100_keab385-B75","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1136\/annrheumdis-2014-206323","article-title":"Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis","volume":"74","author":"Ciccia","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2021102006535429100_keab385-B76","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.immuni.2018.07.007","article-title":"LAG3","volume":"49","author":"Bauch\u00e9","year":"2018","journal-title":"Immunity"},{"key":"2021102006535429100_keab385-B77","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.4049\/jimmunol.1700155","article-title":"The development of steady-state activation hubs between adult LTi ILC3s and primed macrophages in small intestine","volume":"199","author":"Savage","year":"2017","journal-title":"J Immunol"},{"key":"2021102006535429100_keab385-B78","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm.3895","article-title":"IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases","volume":"21","author":"Teng","year":"2015","journal-title":"Nat Med"},{"key":"2021102006535429100_keab385-B79","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa1900750","article-title":"Ustekinumab as induction and maintenance therapy for ulcerative colitis","volume":"381","author":"Sands","year":"2019","journal-title":"N Engl J Med"},{"key":"2021102006535429100_keab385-B80","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.immuni.2015.08.019","article-title":"Differential roles for interleukin-23 and interleukin-17 in intestinal immunoregulation","volume":"43","author":"Maxwell","year":"2015","journal-title":"Immunity"},{"key":"2021102006535429100_keab385-B81","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/art.41169","article-title":"Interleukin-17 inhibition in spondyloarthritis is associated with subclinical gut microbiome perturbations and a distinctive interleukin-25\u2013driven intestinal inflammation","volume":"72","author":"Manasson","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2021102006535429100_keab385-B82","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.immuni.2016.02.007","article-title":"Intestinal interleukin-17 receptor signaling mediates reciprocal control of the gut microbiota and autoimmune inflammation","volume":"44","author":"Kumar","year":"2016","journal-title":"Immunity"},{"key":"2021102006535429100_keab385-B83","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1084\/jem.20071978","article-title":"Regulation of inflammatory responses by IL-17F","volume":"205","author":"Yang","year":"2008","journal-title":"J Exp Med"},{"key":"2021102006535429100_keab385-B84","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.cell.2015.08.058","article-title":"Th17 cell induction by adhesion of microbes to intestinal epithelial cells","volume":"163","author":"Atarashi","year":"2015","journal-title":"Cell"},{"key":"2021102006535429100_keab385-B85","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.immuni.2015.09.003","article-title":"Interleukin-23\u2013independent IL-17 production regulates intestinal epithelial permeability","volume":"43","author":"Lee","year":"2015","journal-title":"Immunity"},{"key":"2021102006535429100_keab385-B86","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.immuni.2011.02.012","article-title":"Functional specialization of interleukin-17 family members","volume":"34","author":"Iwakura","year":"2011","journal-title":"Immunity"},{"key":"2021102006535429100_keab385-B87","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41590-018-0134-y","article-title":"Suppression of IL-17F, but not of IL-17A, provides protection against colitis by inducing Treg cells through modification of the intestinal microbiota","volume":"19","author":"Tang","year":"2018","journal-title":"Nat Immunol"},{"key":"2021102006535429100_keab385-B88","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/annrheumdis-2017-212127","article-title":"Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation","volume":"77","author":"Glatt","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2021102006535429100_keab385-B89","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0140-6736(19)33161-7","article-title":"Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial","volume":"395","author":"Ritchlin","year":"2020","journal-title":"Lancet"},{"key":"2021102006535429100_keab385-B90","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/annrheumdis-2020-216980","article-title":"Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study","volume":"79","author":"van der Heijde","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2021102006535429100_keab385-B91"},{"key":"2021102006535429100_keab385-B92","doi-asserted-by":"crossref","first-page":"e001306","DOI":"10.1136\/rmdopen-2020-001306","article-title":"Dual neutralisation of IL-17F and IL-17A with bimekizumab blocks inflammation-driven osteogenic differentiation of human periosteal cells","volume":"6","author":"Shah","year":"2020","journal-title":"RMD Open"},{"key":"2021102006535429100_keab385-B93","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.3389\/fimmu.2018.01323","article-title":"The interleukin-23\/interleukin-17 axis links adaptive and innate immunity in psoriasis","volume":"9","author":"Sch\u00f6n","year":"2018","journal-title":"Front Immunol"},{"key":"2021102006535429100_keab385-B94","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.4049\/jimmunol.176.3.1908","article-title":"In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin","volume":"176","author":"Piskin","year":"2006","journal-title":"J Immunol"},{"key":"2021102006535429100_keab385-B95","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/2049-2618-1-31","article-title":"Community differentiation of the cutaneous microbiota in psoriasis","volume":"1","author":"Alekseyenko","year":"2013","journal-title":"Microbiome"},{"key":"2021102006535429100_keab385-B96","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00403-011-1189-x","article-title":"Comparison of bacterial microbiota in skin biopsies from normal and psoriatic skin","volume":"304","author":"Fahl\u00e9n","year":"2012","journal-title":"Arch Dermatol Res"},{"key":"2021102006535429100_keab385-B97","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1084\/jem.20090480","article-title":"Self-RNA\u2013antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8","volume":"206","author":"Ganguly","year":"2009","journal-title":"J Exp Med"},{"key":"2021102006535429100_keab385-B98","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.3389\/fimmu.2018.01936","article-title":"Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: new biomarkers in PsA","volume":"9","author":"Frasca","year":"2018","journal-title":"Front Immunol"},{"key":"2021102006535429100_keab385-B99","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1038\/s41598-018-22409-3","article-title":"Cathelicidin promotes inflammation by enabling binding of self-RNA to cell surface scavenger receptors","volume":"8","author":"Takahashi","year":"2018","journal-title":"Sci Rep"},{"key":"2021102006535429100_keab385-B100","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"2021102006535429100_keab385-B101","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","article-title":"Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis","volume":"397","author":"Ghoreschi","year":"2021","journal-title":"Lancet"},{"key":"2021102006535429100_keab385-B102","doi-asserted-by":"crossref","first-page":"8259","DOI":"10.1038\/s41598-020-65269-6","article-title":"Skin expression of IL-23 drives the development of psoriasis and psoriatic arthritis in mice","volume":"10","author":"Chen","year":"2020","journal-title":"Sci Rep"},{"key":"2021102006535429100_keab385-B103","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1172\/JCI126567","article-title":"TYK2 inhibition reduces type 3 immunity and modifies disease progression in murine spondyloarthritis","volume":"130","author":"Gracey","year":"2020","journal-title":"J Clin Invest"},{"key":"2021102006535429100_keab385-B104","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jdermsci.2018.08.001","article-title":"Mechanistic and pharmacological assessment of murine IL-23 mediated psoriasiform dermatitis; implications for drug discovery","volume":"92","author":"Gauld","year":"2018","journal-title":"J Dermatol Sci"},{"key":"2021102006535429100_keab385-B105","doi-asserted-by":"crossref","first-page":"e84634","DOI":"10.1371\/journal.pone.0084634","article-title":"Suppression of molecular inflammatory pathways by Toll-like receptor 7, 8, and 9 antagonists in a model of IL-23\u2013induced skin inflammation","volume":"8","author":"Su\u00e1rez-Fari\u00f1as","year":"2013","journal-title":"PLoS One"},{"key":"2021102006535429100_keab385-B106","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.4049\/jimmunol.1700826","article-title":"IL-17\u2013secreting \u03b3\u03b4 T cells are completely dependent upon CCR6 for homing to inflamed skin","volume":"199","author":"Campbell","year":"2017","journal-title":"J Immunol"},{"key":"2021102006535429100_keab385-B107","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1038\/jid.2014.98","article-title":"IL-23 from Langerhans cells is required for the development of imiquimod-induced psoriasis-like dermatitis by induction of IL-17A\u2013producing \u03b3\u03b4 T cells","volume":"134","author":"Yoshiki","year":"2014","journal-title":"J Invest Dermatol"},{"key":"2021102006535429100_keab385-B108","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.immuni.2011.08.001","article-title":"Pivotal role of dermal IL-17\u2013producing \u03b3\u03b4 T cells in skin inflammation","volume":"35","author":"Cai","year":"2011","journal-title":"Immunity"},{"key":"2021102006535429100_keab385-B109","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.4049\/jimmunol.1100804","article-title":"Identification of a novel proinflammatory human skin-homing V\u03b39V\u03b42 T cell subset with a potential role in psoriasis","volume":"187","author":"Laggner","year":"2011","journal-title":"J Immunol"},{"key":"2021102006535429100_keab385-B110","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.jid.5701213","article-title":"Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells","volume":"128","author":"Lowes","year":"2008","journal-title":"J Invest Dermatol"},{"key":"2021102006535429100_keab385-B111","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1172\/JCI93396","article-title":"Clinically resolved psoriatic lesions contain psoriasis-specific IL-17\u2013producing \u03b1\u03b2 T cell clones","volume":"127","author":"Matos","year":"2017","journal-title":"J Clin Invest"},{"key":"2021102006535429100_keab385-B112","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1084\/jem.20151093","article-title":"Melanocyte antigen triggers autoimmunity in human psoriasis","volume":"212","author":"Arakawa","year":"2015","journal-title":"J Exp Med"},{"key":"2021102006535429100_keab385-B113","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41586-019-1471-1","article-title":"Locally renewing resident synovial macrophages provide a protective barrier for the joint","volume":"572","author":"Culemann","year":"2019","journal-title":"Nature"},{"key":"2021102006535429100_keab385-B114","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jbspin.2017.09.007","article-title":"Impaired intracellular pathogen clearance and inflammatory joint disease: is Whipple\u2019s disease a guiding light?","volume":"85","author":"Berthelot","year":"2018","journal-title":"Joint Bone Spine"},{"key":"2021102006535429100_keab385-B115","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1136\/ard.61.7.580","article-title":"Reactive arthritis or chronic infectious arthritis?","volume":"61","author":"Sibilia","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"2021102006535429100_keab385-B116","doi-asserted-by":"crossref","DOI":"10.1002\/art.41653","article-title":"Chlamydia-infected macrophages mediate interleukin-23 and tumor necrosis factor\u2013driven reactive arthritis in SKG mice","author":"Romand","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"2021102006535429100_keab385-B117","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1136\/annrheumdis-2016-210233","article-title":"An induction or flare of arthritis and\/or sacroiliitis by vedolizumab in inflammatory bowel disease: a case series","volume":"76","author":"Varkas","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2021102006535429100_keab385-B118","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1056\/NEJMra1406182","article-title":"Ankylosing spondylitis and axial spondyloarthritis","volume":"374","author":"Taurog","year":"2016","journal-title":"N Engl J Med"},{"key":"2021102006535429100_keab385-B119","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1096\/fj.03-1367fje","article-title":"Prostaglandin E2 induces IL-23 production in bone marrow\u2013derived dendritic cells","volume":"18","author":"Sheibanie","year":"2004","journal-title":"FASEB J"},{"key":"2021102006535429100_keab385-B120","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41584-018-0091-8","article-title":"Effects of the IL-23\u2013IL-17 pathway on bone in spondyloarthritis","volume":"14","author":"Gravallese","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"2021102006535429100_keab385-B121","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1002\/art.39732","article-title":"Interleukin-23\u2013dependent \u03b3\/\u03b4 T cells produce interleukin-17 and accumulate in the enthesis, aortic valve, and ciliary body in mice","volume":"68","author":"Reinhardt","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2021102006535429100_keab385-B122","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41467-018-07911-6","article-title":"ROR\u03b3t inhibition selectively targets IL-17 producing iNKT and \u03b3\u03b4-T cells enriched in spondyloarthritis patients","volume":"10","author":"Venken","year":"2019","journal-title":"Nat Commun"},{"key":"2021102006535429100_keab385-B123","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/art.40150","article-title":"Brief report: group 3 innate lymphoid cells in human enthesis","volume":"69","author":"Cuthbert","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2021102006535429100_keab385-B124","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1136\/annrheumdis-2019-215210","article-title":"Evidence that tissue resident human enthesis \u03b3\u03b4T-cells can produce IL-17A independently of IL-23R transcript expression","volume":"78","author":"Cuthbert","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2021102006535429100_keab385-B125","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/art.40728","article-title":"Three multicenter, randomized, double-blind, placebo-controlled studies evaluating the efficacy and safety of ustekinumab in axial spondyloarthritis","volume":"71","author":"Deodhar","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2021102006535429100_keab385-B126","doi-asserted-by":"crossref","first-page":"17549","DOI":"10.1073\/pnas.1204327109","article-title":"Interleukin 7 (IL-7) selectively promotes mouse and human IL-17-producing \u03b3\u03b4 cells","volume":"109","author":"Michel","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021102006535429100_keab385-B127","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11926-019-0834-9","article-title":"ILC3 in axial spondyloarthritis: the gut angle","volume":"21","author":"Mauro","year":"2019","journal-title":"Curr Rheumatol Rep"},{"key":"2021102006535429100_keab385-B128","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1136\/annrheumdis-2018-213654","article-title":"Why did IL-23p19 inhibition fail in AS: a tale of tissues, trials or translation?","volume":"78","author":"Siebert","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2021102006535429100_keab385-B129","doi-asserted-by":"crossref","first-page":"e12516","DOI":"10.1371\/journal.pone.0012516","article-title":"Linking power Doppler ultrasound to the presence of Th17 cells in the rheumatoid arthritis joint","volume":"5","author":"Gullick","year":"2010","journal-title":"PLoS One"},{"key":"2021102006535429100_keab385-B130","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/art.23655","article-title":"Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides","volume":"58","author":"Jandus","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2021102006535429100_keab385-B131","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/art.38376","article-title":"Interleukin-17+CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression","volume":"66","author":"Menon","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2021102006535429100_keab385-B132","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/art.41156","article-title":"Polyfunctional, proinflammatory, tissue-resident memory phenotype and function of synovial interleukin-17A+CD8+ T cells in psoriatic arthritis","volume":"72","author":"Steel","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2021102006535429100_keab385-B133","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1002\/art.39681","article-title":"Perturbed mucosal immunity and dysbiosis accompany clinical disease in a rat model of spondyloarthritis","volume":"68","author":"Asquith","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2021102006535429100_keab385-B134","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining trained immunity and its role in health and disease","volume":"20","author":"Netea","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"2021102006535429100_keab385-B135","author":"Souza","year":"2014"},{"key":"2021102006535429100_keab385-B136","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1038\/s41467-020-18513-6","article-title":"Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritis","volume":"11","author":"Penkava","year":"2020","journal-title":"Nat Commun"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab385\/37888545\/keab385.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/Supplement_4\/iv16\/40739812\/keab385.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/Supplement_4\/iv16\/40739812\/keab385.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T00:08:56Z","timestamp":1634774936000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/Supplement_4\/iv16\/6271418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,7]]},"references-count":136,"journal-issue":{"issue":"Supplement_4","published-online":{"date-parts":[[2021,5,7]]},"published-print":{"date-parts":[[2021,10,19]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab385","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,1]]},"published":{"date-parts":[[2021,5,7]]}}}